Compare Amphastar Pharmaceuticals Inc (AMPH) vs Bitdeer Technologies Group (BTDR) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

BTDR trades at $13.29, down 7.26% in the last 24 hours, with a bearish technical signal and recent earnings misses. The company reported revenue growth to $620.25 million in 2025 but a net income margin of -26.96% in 2026, indicating profitability challenges. Positive developments include expansion into AI cloud infrastructure and new facility openings, yet negative cash flow from operations persists.

The outlook is mixed: strong analyst buy consensus (81.82%) and a $23.40 price target suggest upside, but operational losses and Bitcoin market volatility pose significant risks. Investment opportunity lies in AI infrastructure growth, while execution and sector headwinds require careful monitoring.